Published in Cytotechnology on September 01, 2001
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature (1996) 8.37
Conversion of Bcl-2 to a Bax-like death effector by caspases. Science (1997) 4.55
Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem (1997) 2.47
Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res (1996) 2.09
Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med (1999) 1.99
Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J (1997) 1.83
Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng (1994) 1.47
All along the watchtower: on the regulation of apoptosis regulators. FASEB J (1999) 1.24
Cell death in bioreactors: a role for apoptosis. Biotechnol Bioeng (1994) 1.23
Overexpression of bcl-2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng (1995) 1.20
"Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res (1998) 1.14
Cell death (apoptosis) in cell culture systems. Trends Biotechnol (1995) 1.12
Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. Biotechnol Bioeng (1997) 1.09
In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. Biotechnol Bioeng (1998) 1.04
Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Res (1996) 1.02
Starvation-induced programmed death of hybridoma cells: Prevention by amino acid mixtures. Biotechnol Bioeng (1995) 0.99
Involvement of Bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Commun (1998) 0.98
Apoptosis in cell culture. Curr Opin Biotechnol (1998) 0.98
Construction of chimeric molecules by a two-step recombinant PCR method. Biotechniques (1994) 0.94
Anti-apoptotic genes, bag-1 and bcl-2, enabled hybridoma cells to survive under treatment for arresting cell cycle. Cytotechnology (1997) 0.92
Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas. Cytotechnology (1993) 0.91
NSO myeloma cell death: Influence of bcl-2 overexpression. Biotechnol Bioeng (1996) 0.87
Effect of bcl-2 expression on hybridoma cell growth in serum-supplemented, protein-free and diluted media. Cytotechnology (1998) 0.87
Comparison of Bcl-2 to a Bcl-2 deletion mutant for mammalian cells exposed to culture insults. Biotechnol Bioeng (2001) 0.86
Dose-dependent reduction of apoptosis in nutrient-limited cultures of NS/0 myeloma cells transfected with the E1B-19K adenoviral gene. Biotechnol Bioeng (1999) 0.85
Induction of apoptosis in oxygen-deprived cultures of hybridoma cells. Cytotechnology (1994) 0.83
Dephosphorylation-induced decrease of anti-apoptotic function of Bcl-2 in neuronally differentiated P19 cells following ischemic insults. Brain Res (2000) 0.80
Prolongation of murine hybridoma cell survival in stationary batch culture by Bcl-xL expression. Cytotechnology (2000) 0.80
Reinforcing apoptosis-resistance of COS and myeloma cells by transfecting with bcl-2 gene. Cytotechnology (1997) 0.79
Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int (2006) 1.63
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia (2005) 1.33
Effects of the detergent sucrose monolaurate on binding of amphotericin B to sterols and its toxicity for cells. Biochem Biophys Res Commun (1988) 1.01
Two-liquid-phase slurry bioreactors to enhance the degradation of high-molecular-weight polycyclic aromatic hydrocarbons in soil. Biotechnol Prog (2000) 0.88
Expert consensus on management of diabetic patients with impairment of renal function. Diabetes Metab (2011) 0.84
Analysis of outcome after using high-risk criteria selection to surgery versus endovascular repair in the modern era of abdominal aortic aneurysm treatment. Eur J Vasc Endovasc Surg (2010) 0.84
Time course of long-term placebo therapy effects in angina pectoris. Eur Heart J (1986) 0.81
Rapid evaluation in Escherichia coli of antisense RNAs and ribozymes. Lett Appl Microbiol (1998) 0.81
Role of Lu/BCAM in abnormal adhesion of sickle red blood cells to vascular endothelium. Transfus Clin Biol (2008) 0.81
Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs. Endocrinology (1993) 0.80
A one-hour procedure for the preparation of genomic DNA from frozen tissues. Biotechniques (1993) 0.79
Characterization and expression of the prostatic arginine esterase gene, a canine glandular kallikrein. DNA Cell Biol (1991) 0.78
On the reliability of scrape-off layer ion temperature measurements by retarding field analyzers. Rev Sci Instrum (2008) 0.75
[A global intervention program for institutionalized demented patients]. Rev Neurol (Paris) (2005) 0.75
Modeling of the ITER-like wide-angle infrared thermography view of JET. Rev Sci Instrum (2012) 0.75
Failure of a pure anti-platelet drug to decrease the number of attacks more than placebo in patients with Raynaud's phenomenon. Angiology (1986) 0.75
Congenital erythropoietic porphyria: prenatal diagnosis and autopsy findings in two sibling fetuses. Pediatr Dev Pathol (2001) 0.75
Microalbuminuria is not linked to lipoprotein oxidation in nondiabetic obese patients. Nephron (2001) 0.75